Skip to main content

Advertisement

SpringerLink
Log in

Soft Tissue Special Issue: Giant Cell-Rich Lesions of the Head and Neck Region

  • Special Issue: Soft Tissue
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

Giant cell-rich lesions represent a heterogeneous group of tumors and non-neoplastic lesions, usually arising in bone, which harbor varying number of reactive osteoclastic-type multinucleate giant cells as a common feature. Among these entities, some are confined to the head and neck region (e.g., central giant cell granuloma and mimicking lesions, i.e., peripheral giant cell granuloma and cherubism) or show a relative predilection for this region (e.g., aneurysmal bone cyst and brown tumor of hyperparathyroidism), while others are rare but associated with distinct underlying disease (e.g., giant cell tumor of bone) or histology (e.g., tenosynovial giant cell tumor of the temporomandibular joint and phosphaturic mesenchymal tumor of the jaws) when occurring in the head and neck. Collectively, these lesions pose great challenge in the pathologic diagnosis, which often requires combinatory assessment from the clinical, histopathologic, and/or molecular aspects. This review provides a summary of pertinent clinical and pathologic features and an update of recent molecular and genetic findings of these entities. The considerations in differential diagnosis as well as the effects of the emerging therapeutic RANKL-antagonizing antibody denosumab will also be addressed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Athanasou NA, Bansal M, Forsyth R, Reid RP, Sapi Z. Giant cell tumour of bone. In: Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, editors. World Health Organization classification of tumours of soft tissue and bone. Lyon: IARC Press; 2013. p. 321–4.

    Google Scholar 

  2. Dahlin DC, Cupps RE, Johnson EW Jr. Giant-cell tumor: a study of 195 cases. Cancer. 1970;25(5):1061–70.

    CAS  PubMed  Google Scholar 

  3. Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am. 1987;69(1):106–14.

    CAS  PubMed  Google Scholar 

  4. Unni KK, Inwards CY. Dahlin’s bone tumors. 6th ed. Philadelphia: LWW; 2010.

    Google Scholar 

  5. Huvos AG. Bone tumors: diagnosis, treatment, and prognosis. 2nd ed. Philadelphia: WB Saunders; 1991.

    Google Scholar 

  6. Bertoni F, Unni KK, Beabout JW, Ebersold MJ. Giant cell tumor of the skull. Cancer. 1992;70(5):1124–32.

    CAS  PubMed  Google Scholar 

  7. Czerniak B. Dorfman and Czerniak’s bone tumors. 2nd ed. Philadelphia: Saunders; 2016.

    Google Scholar 

  8. Wieneke JA, Gannon FH, Heffner DK, Thompson LD. Giant cell tumor of the larynx: a clinicopathologic series of eight cases and a review of the literature. Mod Pathol. 2001;14(12):1209–15.

    CAS  PubMed  Google Scholar 

  9. Vigorita VJ. Orthopaedic pathology. 3rd ed. Philadelphia: LWW; 2016.

    Google Scholar 

  10. Zheng MH, Robbins P, Xu J, Huang L, Wood DJ, Papadimitriou JM. The histogenesis of giant cell tumour of bone: a model of interaction between neoplastic cells and osteoclasts. Histol Histopathol. 2001;16(1):297–307.

    CAS  PubMed  Google Scholar 

  11. Wuelling M, Engels C, Jesse N, Werner M, Kaiser E, Delling G. Histogenesis of giant cell tumors. Pathologe. 2002;23(5):332–9.

    CAS  PubMed  Google Scholar 

  12. Lau YS, Sabokbar A, Gibbons CL, Giele H, Athanasou N. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue. Hum Pathol. 2005;36(9):945–54.

    CAS  PubMed  Google Scholar 

  13. Meis JM, Dorfman HD, Nathanson SD, Haggar AM, Wu KK. Primary malignant giant cell tumor of bone: “dedifferentiated” giant cell tumor. Mod Pathol. 1989;2(5):541–6.

    CAS  PubMed  Google Scholar 

  14. Brien EW, Mirra JM, Kessler S, Suen M, Ho JK, Yang WT. Benign giant cell tumor of bone with osteosarcomatous transformation (“dedifferentiated” primary malignant GCT): report of two cases. Skelet Radiol. 1997;26(4):246–55.

    CAS  Google Scholar 

  15. Wojcik J, Rosenberg AE, Bredella MA, Choy E, Hornicek FJ, Nielsen GP, et al. Denosumab-treated Giant cell tumor of bone exhibits morphologic overlap with malignant giant cell tumor of bone. Am J Surg Pathol. 2016;40(1):72–80.

    PubMed  Google Scholar 

  16. Chan J, Gannon FH, Thompson LD. Malignant giant cell tumor of the sphenoid. Ann Diagn Pathol. 2003;7(2):100–5.

    PubMed  Google Scholar 

  17. Karamanakos PN, Jaaskelainen JE, Alafuzoff I, Pirinen E, Vanninen R, Silvennoinen S, et al. Malignant giant cell tumor in the posterior fossa of a neonate. J Neurosurg Pediatr. 2010;5(3):277–82.

    PubMed  Google Scholar 

  18. Vivero RJ, Dave SP, Gomez CR, Weed DT. Giant cell tumor of the larynx: a case of malignant sarcomatous transformation. Ear Nose Throat J. 2013;92(6):E59.

    PubMed  Google Scholar 

  19. Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N, Van Loo P, et al. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet. 2013;45(12):1479–82.

    CAS  PubMed  Google Scholar 

  20. Cleven AH, Hocker S, Briaire-de Bruijn I, Szuhai K, Cleton-Jansen AM, Bovee JV. Mutation analysis of H3F3A and H3F3B as a diagnostic tool for giant cell tumor of bone and chondroblastoma. Am J Surg Pathol. 2015;39(11):1576–83.

    PubMed  Google Scholar 

  21. Al-Ibraheemi A, Inwards CY, Zreik RT, Wenger DE, Jenkins SM, Carter JM, et al. Histologic spectrum of giant cell tumor (GCT) of bone in patients 18 years of age and below: a study of 63 patients. Am J Surg Pathol. 2016;40:1702–12.

    PubMed  Google Scholar 

  22. Girolami I, Mancini I, Simoni A, Baldi GG, Simi L, Campanacci D, et al. Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series. J Clin Pathol. 2016;69(3):240–7.

    CAS  PubMed  Google Scholar 

  23. Amary F, Berisha F, Ye H, Gupta M, Gutteridge A, Baumhoer D, et al. H3F3A (Histone 3.3) G34W Immunohistochemistry: a reliable marker defining benign and malignant giant cell tumor of bone. Am J Surg Pathol. 2017;41(8):1059–68.

    PubMed  PubMed Central  Google Scholar 

  24. Yamamoto H, Iwasaki T, Yamada Y, Matsumoto Y, Otsuka H, Yoshimoto M, et al. Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone. Hum Pathol. 2018;73:41–50.

    CAS  PubMed  Google Scholar 

  25. Yoshida KI, Nakano Y, Honda-Kitahara M, Wakai S, Motoi T, Ogura K, et al. Absence of H3F3A mutation in a subset of malignant giant cell tumor of bone. Mod Pathol. 2019;32:1751–61.

    CAS  PubMed  Google Scholar 

  26. Vergel De Dios AM, Bond JR, Shives TC, McLeod RA, Unni KK. Aneurysmal bone cyst. A clinicopathologic study of 238 cases. Cancer. 1992;69(12):2921–31.

    CAS  PubMed  Google Scholar 

  27. Bataineh AB. Aneurysmal bone cysts of the maxilla: a clinicopathologic review. J Oral Maxillofac Surg. 1997;55(11):1212–6.

    CAS  PubMed  Google Scholar 

  28. Mankin HJ, Hornicek FJ, Ortiz-Cruz E, Villafuerte J, Gebhardt MC. Aneurysmal bone cyst: a review of 150 patients. J Clin Oncol. 2005;23(27):6756–62.

    PubMed  Google Scholar 

  29. Fennessy BG, Vargas SO, Silvera MV, Ohlms LA, McGill TJ, Healy GB, et al. Paediatric aneurysmal bone cysts of the head and neck. J Laryngol Otol. 2009;123(6):635–41.

    CAS  PubMed  Google Scholar 

  30. Song W, Suurmeijer AJH, Bollen SM, Cleton-Jansen AM, Bovee J, Kroon HM. Soft tissue aneurysmal bone cyst: six new cases with imaging details, molecular pathology, and review of the literature. Skelet Radiol. 2019;48(7):1059–67.

    Google Scholar 

  31. Li HR, Tai CF, Huang HY, Jin YT, Chen YT, Yang SF. USP6 gene rearrangement differentiates primary paranasal sinus solid aneurysmal bone cyst from other giant cell-rich lesions: report of a rare case. Hum Pathol. 2018;76:117–21.

    CAS  PubMed  Google Scholar 

  32. Sanerkin NG, Mott MG, Roylance J. An unusual intraosseous lesion with fibroblastic, osteoclastic, osteoblastic, aneurysmal and fibromyxoid elements “Solid” variant of aneurysmal bone cyst. Cancer. 1983;51(12):2278–86.

    CAS  PubMed  Google Scholar 

  33. Bertoni F, Bacchini P, Capanna R, Ruggieri P, Biagini R, Ferruzzi A, et al. Solid variant of aneurysmal bone cyst. Cancer. 1993;71(3):729–34.

    CAS  PubMed  Google Scholar 

  34. Martinez V, Sissons HA. Aneurysmal bone cyst. A review of 123 cases including primary lesions and those secondary to other bone pathology. Cancer. 1988;61(11):2291–304.

    CAS  PubMed  Google Scholar 

  35. Gnepp D. Diagnostic surgical pathology of the head and neck. 2nd ed. Philadelphia: Saunders; 2009.

    Google Scholar 

  36. Oliveira AM, Perez-Atayde AR, Inwards CY, Medeiros F, Derr V, Hsi BL, et al. USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts. Am J Pathol. 2004;165(5):1773–80.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Dal Cin P, Kozakewich HP, Goumnerova L, Mankin HJ, Rosenberg AE, Fletcher JA. Variant translocations involving 16q22 and 17p13 in solid variant and extraosseous forms of aneurysmal bone cyst. Genes Chromosomes Cancer. 2000;28(2):233–4.

    Google Scholar 

  38. Blackburn PR, Davila JI, Jackson RA, Fadra N, Atiq MA, Pitel BA, et al. RNA sequencing identifies a novel USP9X-USP6 promoter swap gene fusion in a primary aneurysmal bone cyst. Genes Chromosomes Cancer. 2019;58(8):589–94.

    CAS  PubMed  Google Scholar 

  39. Oliveira AM, Chou MM. The TRE17/USP6 oncogene: a riddle wrapped in a mystery inside an enigma. Front Biosci (Schol Ed). 2012;4:321–34.

    PubMed  Google Scholar 

  40. Chrcanovic BR, Gomes CC, Gomez RS. Central giant cell lesion of the jaws: an updated analysis of 2270 cases reported in the literature. J Oral Pathol Med. 2018;47(8):731–9.

    PubMed  Google Scholar 

  41. Vered M, Buchner A, Dayan D. Central giant cell granuloma of the jawbones–new insights into molecular biology with clinical implications on treatment approaches. Histol Histopathol. 2008;23(9):1151–60.

    PubMed  Google Scholar 

  42. Gomes CC, Gayden T, Bajic A, Harraz OF, Pratt J, Nikbakht H, et al. TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw. Nat Commun. 2018;9(1):4572.

    PubMed  PubMed Central  Google Scholar 

  43. Baumhoer D, Kovac M, Sperveslage J, Ameline B, Strobl AC, Krause A, et al. Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of bone. J Pathol. 2019;248(1):116–22.

    CAS  PubMed  Google Scholar 

  44. Mangion J, Rahman N, Edkins S, Barfoot R, Nguyen T, Sigurdsson A, et al. The gene for cherubism maps to chromosome 4p16.3. Am J Hum Genet. 1999;65(1):151–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Flanagan AM, Speight PM. Giant cell lesions of the craniofacial bones. Head Neck Pathol. 2014;8(4):445–53.

    PubMed  PubMed Central  Google Scholar 

  46. Boland JM, Folpe AL, Hornick JL, Grogg KL. Clusterin is expressed in normal synoviocytes and in tenosynovial giant cell tumors of localized and diffuse types: diagnostic and histogenetic implications. Am J Surg Pathol. 2009;33(8):1225–9.

    PubMed  Google Scholar 

  47. Al-Ibraheemi A, Ahrens WA, Fritchie K, Dong J, Oliveira AM, Balzer B, et al. Malignant tenosynovial giant cell tumor: the true “Synovial Sarcoma?” A clinicopathologic, immunohistochemical, and molecular cytogenetic study of 10 cases, supporting origin from synoviocytes. Mod Pathol. 2019;32(2):242–51.

    CAS  PubMed  Google Scholar 

  48. Verspoor FGM, Mastboom MJL, Weijs WLJ, Koetsveld AC, Schreuder HWB, Flucke U. Treatments of tenosynovial giant cell tumours of the temperomandibular joint: a report of three cases and a review of literature. Int J Oral Maxillofac Surg. 2018;47(10):1288–94.

    CAS  PubMed  Google Scholar 

  49. Cho JM, Chang JH, Kim SH, Lee KS. Pediatric giant cell tumor of the tendon sheath of the craniocervical junction involving the occipital condyle. Childs Nerv Syst. 2016;32(1):175–9.

    PubMed  Google Scholar 

  50. Gelinne A, Akture E, Tranmer B. Tenosynovial giant cell tumor of the clinoid: rare condition. World Neurosurg. 2018;118:168–71.

    PubMed  Google Scholar 

  51. Mastboom MJL, Verspoor FGM, Verschoor AJ, Uittenbogaard D, Nemeth B, Mastboom WJB, et al. Higher incidence rates than previously known in tenosynovial giant cell tumors. Acta Orthop. 2017;88(6):688–94.

    PubMed  PubMed Central  Google Scholar 

  52. Romanach MJ, Brasileiro BF, Leon JE, Alves DB, de Almeida OP, Vargas PA. Pigmented villonodular synovitis of the temporomandibular joint: case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111(3):e17–28.

    PubMed  Google Scholar 

  53. Chow LT, Kumta SM, King WW. Extra-articular pigmented villonodular synovitis of the temporomandibular joint. J Laryngol Otol. 1998;112(2):182–5.

    CAS  PubMed  Google Scholar 

  54. Carlson ML, Osetinsky LM, Alon EE, Inwards CY, Lane JI, Moore EJ. Tenosynovial giant cell tumors of the temporomandibular joint and lateral skull base: review of 11 cases. Laryngoscope. 2017;127(10):2340–6.

    PubMed  Google Scholar 

  55. Safaee M, Oh T, Sun MZ, Parsa AT, McDermott MW, El-Sayed IH, et al. Pigmented villonodular synovitis of the temporomandibular joint with intracranial extension: a case series and systematic review. Head Neck. 2015;37(8):1213–24.

    PubMed  Google Scholar 

  56. Herman CR, Swift JQ, Schiffman EL. Pigmented villonodular synovitis of the temporomandibular joint with intracranial extension: a case and literature review. Int J Oral Maxillofac Surg. 2009;38(7):795–801.

    CAS  PubMed  Google Scholar 

  57. Murphey MD, Rhee JH, Lewis RB, Fanburg-Smith JC, Flemming DJ, Walker EA. Pigmented villonodular synovitis: radiologic-pathologic correlation. Radiographics. 2008;28(5):1493–518.

    PubMed  Google Scholar 

  58. Wang JG, Liu J, He B, Gao L, Zhang L, Liu J. Diffuse tenosynovial giant cell tumor around the temporomandibular joint: an entity with special radiologic and pathologic features. J Oral Maxillofac Surg. 2019;77(5):1022e1-e39.

    Google Scholar 

  59. Cai XY, Yang C, Chen MJ, Yun B. Simultaneous pigmented villonodular synovitis and synovial chondromatosis of the temporomandibular joint: case report. Int J Oral Maxillofac Surg. 2009;38(11):1215–8.

    PubMed  Google Scholar 

  60. Oda Y, Izumi T, Harimaya K, Segawa Y, Ishihara S, Komune S, et al. Pigmented villonodular synovitis with chondroid metaplasia, resembling chondroblastoma of the bone: a report of three cases. Mod Pathol. 2007;20(5):545–51.

    PubMed  Google Scholar 

  61. Kurt AM, Unni KK, Sim FH, McLeod RA. Chondroblastoma of bone. Hum Pathol. 1989;20(10):965–76.

    CAS  PubMed  Google Scholar 

  62. Hoch BL, Garcia RA, Smalberger GJ. Chondroid tenosynovial giant cell tumor: a clinicopathological and immunohistochemical analysis of 5 new cases. Int J Surg Pathol. 2011;19(2):180–7.

    PubMed  Google Scholar 

  63. Yoon HJ, Cho YA, Lee JI, Hong SP, Hong SD. Malignant pigmented villonodular synovitis of the temporomandibular joint with lung metastasis: a case report and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111(5):e30–6.

    PubMed  Google Scholar 

  64. Bertoni F, Unni KK, Beabout JW, Sim FH. Malignant giant cell tumor of the tendon sheaths and joints (malignant pigmented villonodular synovitis). Am J Surg Pathol. 1997;21(2):153–63.

    CAS  PubMed  Google Scholar 

  65. Li CF, Wang JW, Huang WW, Hou CC, Chou SC, Eng HL, et al. Malignant diffuse-type tenosynovial giant cell tumors: a series of 7 cases comparing with 24 benign lesions with review of the literature. Am J Surg Pathol. 2008;32(4):587–99.

    PubMed  Google Scholar 

  66. West RB, Rubin BP, Miller MA, Subramanian S, Kaygusuz G, Montgomery K, et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci USA. 2006;103(3):690–5.

    CAS  PubMed  Google Scholar 

  67. Cupp JS, Miller MA, Montgomery KD, Nielsen TO, O’Connell JX, Huntsman D, et al. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides. Am J Surg Pathol. 2007;31(6):970–6.

    PubMed  Google Scholar 

  68. Mastboom MJL, Hoek DM, Bovee J, van de Sande MAJ, Szuhai K. Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee? Histopathology. 2019;74(2):332–40.

    PubMed  Google Scholar 

  69. Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol. 2004;28(1):1–30.

    PubMed  Google Scholar 

  70. Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA. 2001;98(11):6500–5.

    CAS  PubMed  Google Scholar 

  71. Boland JM, Tebben PJ, Folpe AL. Phosphaturic mesenchymal tumors: what an endocrinologist should know. J Endocrinol Invest. 2018;41(10):1173–84.

    CAS  PubMed  Google Scholar 

  72. Hodgson SF, Clarke BL, Tebben PJ, Mullan BP, Cooney WP 3rd, Shives TC. Oncogenic osteomalacia: localization of underlying peripheral mesenchymal tumors with use of Tc 99m sestamibi scintigraphy. Endocr Pract. 2006;12(1):35–42.

    PubMed  Google Scholar 

  73. Shih YH, Chen HC, Liao SC, Tseng MC, Lee MB. Psychotic disorder due to phosphaturic mesenchymal tumor with mixed connective tissue variant. Psychosomatics. 2012;53(1):96–7.

    PubMed  Google Scholar 

  74. Garcia CA, Spencer RP. Bone and In-111 octreotide imaging in oncogenic osteomalacia: a case report. Clin Nucl Med. 2002;27(8):582–3.

    PubMed  Google Scholar 

  75. Siegel HJ, Rock MG. Occult phosphaturic mesenchymal tumor detected by Tc-99m sestamibi scan. Clin Nucl Med. 2002;27(8):608–9.

    PubMed  Google Scholar 

  76. El-Maouche D, Sadowski SM, Papadakis GZ, Guthrie L, Cottle-Delisle C, Merkel R, et al. (68)Ga-DOTATATE for tumor localization in tumor-induced osteomalacia. J Clin Endocrinol Metab. 2016;101(10):3575–81.

    CAS  PubMed  PubMed Central  Google Scholar 

  77. Sundaram M, McCarthy EF. Oncogenic osteomalacia. Skelet Radiol. 2000;29(3):117–24.

    CAS  Google Scholar 

  78. Bahrami A, Weiss SW, Montgomery E, Horvai AE, Jin L, Inwards CY, et al. RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia. Am J Surg Pathol. 2009;33(9):1348–54.

    PubMed  Google Scholar 

  79. Weidner N, Santa Cruz D. Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets. Cancer. 1987;59(8):1442–54.

    CAS  PubMed  Google Scholar 

  80. Shelekhova KV, Kazakov DV, Hes O, Treska V, Michal M. Phosphaturic mesenchymal tumor (mixed connective tissue variant): a case report with spectral analysis. Virchows Arch. 2006;448(2):232–5.

    PubMed  Google Scholar 

  81. Ogose A, Hotta T, Emura I, Hatano H, Inoue Y, Umezu H, et al. Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia. Skelet Radiol. 2001;30(2):99–103.

    CAS  Google Scholar 

  82. Uramoto N, Furukawa M, Yoshizaki T. Malignant phosphaturic mesenchymal tumor, mixed connective tissue variant of the tongue. Auris Nasus Larynx. 2009;36(1):104–5.

    PubMed  Google Scholar 

  83. Wu H, Bui MM, Zhou L, Li D, Zhang H, Zhong D. Phosphaturic mesenchymal tumor with an admixture of epithelial and mesenchymal elements in the jaws: clinicopathological and immunohistochemical analysis of 22 cases with literature review. Mod Pathol. 2019;32(2):189–204.

    CAS  PubMed  Google Scholar 

  84. Agaimy A, Michal M, Chiosea S, Petersson F, Hadravsky L, Kristiansen G, et al. Phosphaturic mesenchymal tumors: clinicopathologic, immunohistochemical and molecular analysis of 22 cases expanding their morphologic and immunophenotypic spectrum. Am J Surg Pathol. 2017;41(10):1371–80.

    PubMed  Google Scholar 

  85. Yamada Y, Kinoshita I, Kenichi K, Yamamoto H, Iwasaki T, Otsuka H, et al. Histopathological and genetic review of phosphaturic mesenchymal tumours, mixed connective tissue variant. Histopathology. 2018;72(3):460–71.

    PubMed  Google Scholar 

  86. Lee JC, Su SY, Changou CA, Yang R-S, Tsai K-S, Collins MT, et al. Characterization of FN1-FGFR1 and Novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors. Mod Pathol. 2016;29(11):1335–46.

    CAS  PubMed  Google Scholar 

  87. Tajima S, Fukayama M. Fibroblast growth factor receptor 1 (FGFR1) expression in phosphaturic mesenchymal tumors. Int J Clin Exp Pathol. 2015;8(8):9422–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  88. Carter JM, Caron BL, Dogan A, Folpe AL. A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors. Am J Surg Pathol. 2015;39(1):75–83.

    PubMed  Google Scholar 

  89. Lee JC, Jeng YM, Su SY, Wu CT, Tsai KS, Lee CH, et al. Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour. J Pathol. 2015;235(4):539–45.

    CAS  PubMed  Google Scholar 

  90. Grulois V, Buysschaert I, Schoenaers J, Debruyne F, Delaere P, Vander Poorten V. Brown tumour: presenting symptom of primary hyperparathyroidism. B-ENT. 2005;1(4):191–5.

    CAS  PubMed  Google Scholar 

  91. Hong WS, Sung MS, Chun KA, Kim JY, Park SW, Lee KH, et al. Emphasis on the MR imaging findings of brown tumor: a report of five cases. Skelet Radiol. 2011;40(2):205–13.

    CAS  Google Scholar 

  92. Branstetter DG, Nelson SD, Manivel JC, Blay JY, Chawla S, Thomas DM, et al. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone. Clin Cancer Res. 2012;18(16):4415–24.

    CAS  PubMed  Google Scholar 

  93. Thomas DM. RANKL, denosumab, and giant cell tumor of bone. Curr Opin Oncol. 2012;24(4):397–403.

    CAS  PubMed  Google Scholar 

  94. Stagner AM, Sajed DP, Nielsen GP, Ebb DH, Faquin WC, Chebib I, et al. Giant cell lesions of the maxillofacial skeleton express RANKL by RNA in situ hybridization regardless of histologic pattern. Am J Surg Pathol. 2019;43(6):819–26.

    PubMed  Google Scholar 

  95. Won KY, Kalil RK, Kim YW, Park YK. RANK signalling in bone lesions with osteoclast-like giant cells. Pathology. 2011;43(4):318–21.

    PubMed  Google Scholar 

  96. O’Connell JE, Bowe C, Murphy C, Toner M, Kearns GJ. Aggressive giant cell lesion of the jaws: a review of management options and report of a mandibular lesion treated with denosumab. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120(5):e191–8.

    PubMed  Google Scholar 

  97. Schreuder WH, Coumou AW, Kessler PA, de Lange J. Alternative pharmacologic therapy for aggressive central giant cell granuloma: denosumab. J Oral Maxillofac Surg. 2014;72(7):1301–9.

    PubMed  Google Scholar 

  98. Palmerini E, Ruggieri P, Angelini A, Boriani S, Campanacci D, Milano GM, et al. Denosumab in patients with aneurysmal bone cysts: a case series with preliminary results. Tumori. 2018;104(5):344–51.

    CAS  PubMed  PubMed Central  Google Scholar 

  99. Kurucu N, Akyuz C, Ergen FB, Yalcin B, Kosemehmetoglu K, Ayvaz M, et al. Denosumab treatment in aneurysmal bone cyst: evaluation of nine cases. Pediatr Blood Cancer. 2018. https://doi.org/10.1002/pbc.26926.

    Article  PubMed  Google Scholar 

  100. Florenzano P, Gafni RI, Collins MT. Tumor-induced osteomalacia. Bone Rep. 2017;7:90–7.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgement

The authors thank Drs. Yu-Chien Kao, Wan-Shan Li, Chih-Hsueh Chen, and Yo-Chun Lin for providing kind assistance and precious cases.

Funding

This work was not supported by any research fund.

Author information

Authors and Affiliations

  1. Department and Graduate Institute of Pathology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan

    Jen-Chieh Lee

  2. Department of Anatomical Pathology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, 123 Ta-Pei Road, Niao-Sung District, Kaohsiung, 833, Taiwan

    Hsuan-Ying Huang

Authors
  1. Jen-Chieh Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hsuan-Ying Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hsuan-Ying Huang.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, JC., Huang, HY. Soft Tissue Special Issue: Giant Cell-Rich Lesions of the Head and Neck Region. Head and Neck Pathol 14, 97–108 (2020). https://doi.org/10.1007/s12105-019-01086-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-019-01086-2

Keywords

Search

Navigation